drugset
drugset / Trial / NCT04136262

Tripterygium Wilfordii Hook F and Methotrexate for Postmenopausal Women With Rheumatoid Arthritis

NCT04136262 ↗

Phase 2/3 Unknown 300 enrolled Guang'anmen Hospital of China Academy of Chinese Medical Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a multicenter, randomized, double-blinded, controlled trial with two parallel arms. The aim of the study is to evaluate whether Tripterygium wilfordii Hook F combined with methotrexate (MTX) might be better than MTX alone for postmenopausal women with active rheumatoid arthritis (RA).

Timeline

Start
2019-11-25
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 10 mg Oral
Subject Tripterygium wilfordii Hook F Traditional medicine (herbal / TCM) 20 mg Oral

Indications

rheumatoid arthritis